Metropolis Healthcare Ltd. engages in the provision of medical laboratories. The company is headquartered in Mumbai, Maharashtra and currently employs 4,314 full-time employees. The company went IPO on 2019-04-15. The firm has a single operating segment, namely Pathology service. The company is mainly engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The firm serves both the business-to-business (B2B) and business-to-customer (B2C) markets. The company offers a comprehensive range of over 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. The firm operates approximately 200 clinical laboratories and 4,300 service centers across 22 states in India.